Entia
Entia develops the Liberty home blood monitoring system, which allows patients to perform clinical-grade tests using a single drop of blood. The platform provides immediate results for electrolytes, cardiovascular markers, and haematology, specifically targeting patients undergoing cancer treatment and those with chronic conditions. The system integrates with healthcare providers by seamlessly sharing results to inform treatment decisions.
Visit websiteLondon, UK
Healthtech
Medical Devices
Diagnostics
Funding summary
- Total raised
- €38.8M
- Funding rounds
- 3
Investors in Entia
Investors on record for Entia. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Entia?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors